Stock Quote
GlaxoSmithKline PLC (GSK.L) (London Stock Exchange)
1,277.50p
23 Nov 2009
+1.91%
1,253.50p
1,262.00p
8,848,114
1,286.00p
1,259.00p
1,319.00p
982.00p
0.43
8,221,007
GSK.L
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Gent, Christopher | Non-Executive Chairman of the Board | 651,000 |
| Witty, Andrew | Chief Executive Officer, Executive Director | 1,778,000 |
| Heslop, Julian | Chief Financial Officer, Executive Director | 926,000 |
Profile
GlaxoSmithKline plc (GSK) is a global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical... Full Description
Company Address
GlaxoSmithKline PLC
980 Great West Road
Brentford
Middlesex ENG TW8 9GS
P: +4420.80475000
F: +4420.80477807
980 Great West Road
Brentford
Middlesex ENG TW8 9GS
P: +4420.80475000
F: +4420.80477807
Analyst Research
| GSK.L | Industry | |
|---|---|---|
| P/E(TTM) | 13.10 | 6.90 |
| P/S(TTM) | 2.39 | 1.54 |
| ROI(TTM) | 18.34 | 6.18 |
| ROE(TTM) | 58.25 | 9.32 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 27.80 |
| EPS Est. (Current Year) | 120.50 |
| Total Revenue | $6,758.00M |
| Net Income | $1,371.00M |
| EPS | $0.26 |
